Skip to main content

Clinical Trials: Coronavirus

Question for Department of Health and Social Care

UIN 58850, tabled on 19 October 2021

To ask the Secretary of State for Health and Social Care, what assessment he has made of impact of the reduction of clinical trials during the covid-19 outbreak on (a) the NHS and (b) medical research; and what step his Department is taking to support clinical trials and research to recover from the covid-19 outbreak.

This answer is the replacement for a previous holding answer.

Answered on

25 November 2021

During the pandemic research continued and there was no reduction in the number of clinical trials. However, non-COVID-19 studies were impacted by reductions in research delivery capacity and NHS services and many sponsors, funders and sites paused their studies. As of 31 March 2021, 81% of paused commercial studies and 77% non-commercial studies on the National Institute for Health Research’s Clinical Research Network portfolio had restarted. In June 2021, the Government published The Future of UK Clinical Research Delivery: 2021 to 2022 implementation plan to outline how we will support the recovery of research studies.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.